onderzoek Astellas begins phase 3 trials of fezolinetant in postmenopausal women with vasomotor symptoms 12 augustus 2019Pharma Biz
onderzoek AstraZeneca’s Lynparza meets primary endpoint in Phase 3 prostate cancer trial 12 augustus 2019InPharm.com
wet- en regelgeving European approval for two new delivery formulations of GSK’s Nucala in severe eosinophilic asthma 12 augustus 2019InPharm.com
wet- en regelgeving Sanofi’s Dupixent extended in Europe to cover adolescents in atopic dermatits 12 augustus 2019InPharm.com
wet- en regelgeving EMA committee recommends approval of Merck’s Zerbaxa 3g dose to treat adults with HAP, including VAP 12 augustus 2019Pharma Biz
marketing How to Match Your Content to the Best Distribution Channel 1 augustus 2019Content Marketing Institute
